Home› Situations› IONS — Profile and price weak
Situation · 2026-08-07

IONS — Profile and price weak

Premium Rides on Pipeline, Not Profits

Updated 2026-08-03 · Ref: Biotechnology
Key metrics — 2026-08-03
Peer score
39
Quality pct
21
Valuation pct
30
52w drawdown
-37.0%
21d vs sector
-30.1%
Peer group
Biotechnology
Situation summary

Ionis trades on pipeline hopes, not profits. With -47.7% operating margin, every clinical setback shakes the stock. The market buys the story, not the numbers. One bad trial, and the price drops hard.

Published by AssetNext · 2026-08-09

All companies with this signal today

View full list: Profile and price weak →

Related pages for IONS
Full peer analysis for Ionis Pharmaceuticals, Inc. →Similar companies to IONSIONS peersAll IONS comparisonsRussell 1000 context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-08-03 Profile and price weak 39 -37.0% -30.1%
2026-07-21 Profile and price weak 39 -38.3% -38.5%

See IONS's full peer analysis

Break down IONS's structural position across all peer dimensions with the interactive app.

Open IONS in AssetNext →